Published in Cancer Weekly, March 30th, 2004
"The two-compartment pharmacokinetics exhibited by iodinated contrast media makes these agents well suited to the study of tumor angiogenesis in which new vessels are not only produced in greater number but also are abnormally permeable to circulating molecules," according to researchers in UK.
"The temporal changes in contrast enhancement of tumors on computed tomography (CT) have been shown to correlate with histopathological assessments of angiogenesis with the intravascular and extravascular phases of contrast enhancement reflecting microvessel density and vascular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.